GAST and pancreatic adenocarcinoma: Gastrin mediates its effect via the cholecystokinin-2 receptor (CCK2R), primarily expressed by enterochromaffin-like (ECL) cells, but also reported to be expressed in cancer like colorectal and pancreatic adenocarcinomas [10-12].